Literature DB >> 10908108

F-12509A, a new sphingosine kinase inhibitor, produced by a discomycete.

K Kono1, M Tanaka, T Ogita, T Hosoya, T Kohama.   

Abstract

In the course of our screening for inhibitors of sphingosine kinase, we found an active compound from a culture broth of a discomycete, Trichopezizella barbata SANK 25395. The structure of the compound, named F-12509A, was elucidated by a combination of spectroscopic analyses, to be a new sesquiterpene quinone consisting of a drimane moiety and a dihydroxybenzoquinone. Enzyme kinetic analyses showed that F-12509A inhibits sphingosine kinase activity in a competitive manner with respect to sphingosine, with a Ki value of 18 microM.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10908108     DOI: 10.7164/antibiotics.53.459

Source DB:  PubMed          Journal:  J Antibiot (Tokyo)        ISSN: 0021-8820            Impact factor:   2.649


  10 in total

1.  The sphingosine kinase 1 inhibitor 2-(p-hydroxyanilino)-4-(p-chlorophenyl)thiazole induces proteasomal degradation of sphingosine kinase 1 in mammalian cells.

Authors:  Carolyn Loveridge; Francesca Tonelli; Tamara Leclercq; Keng Gat Lim; Jaclyn S Long; Evgeny Berdyshev; Rothwelle J Tate; Viswanathan Natarajan; Stuart M Pitson; Nigel J Pyne; Susan Pyne
Journal:  J Biol Chem       Date:  2010-10-06       Impact factor: 5.157

2.  Determination of sphingosine kinase activity for cellular signaling studies.

Authors:  Katherine J Lee; Simon M Mwongela; Sumith Kottegoda; Laura Borland; Allison R Nelson; Christopher E Sims; Nancy L Allbritton
Journal:  Anal Chem       Date:  2008-01-16       Impact factor: 6.986

Review 3.  Targeting the sphingosine kinase/sphingosine 1-phosphate pathway in disease: review of sphingosine kinase inhibitors.

Authors:  K Alexa Orr Gandy; Lina M Obeid
Journal:  Biochim Biophys Acta       Date:  2012-07-16

Review 4.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

Review 5.  Ceramide in apoptosis: a revisited role.

Authors:  Thierry Levade; Sophie Malagarie-Cazenave; Valérie Gouazé; Bruno Ségui; Claudine Tardy; Susan Betito; Nathalie Andrieu-Abadie; Olivier Cuvillier
Journal:  Neurochem Res       Date:  2002-08       Impact factor: 3.996

Review 6.  Sphingosine 1-phosphate and cancer.

Authors:  Nigel J Pyne; Susan Pyne
Journal:  Nat Rev Cancer       Date:  2010-06-17       Impact factor: 60.716

7.  Dynamic regulation of sphingosine-1-phosphate homeostasis during development of mouse metanephric kidney.

Authors:  R Jason Kirby; Ying Jin; Jian Fu; Jimena Cubillos; Debi Swertfeger; Lois J Arend
Journal:  Am J Physiol Renal Physiol       Date:  2008-12-10

Review 8.  "Inside-out" signaling of sphingosine-1-phosphate: therapeutic targets.

Authors:  Kazuaki Takabe; Steven W Paugh; Sheldon Milstien; Sarah Spiegel
Journal:  Pharmacol Rev       Date:  2008-06-13       Impact factor: 25.468

9.  Purpurogemutantin and purpurogemutantidin, new drimenyl cyclohexenone derivatives produced by a mutant obtained by diethyl sulfate mutagenesis of a marine-derived Penicillium purpurogenum G59.

Authors:  Shi-Ming Fang; Cheng-Bin Cui; Chang-Wei Li; Chang-Jing Wu; Zhi-Jun Zhang; Li Li; Xiao-Jun Huang; Wen-Cai Ye
Journal:  Mar Drugs       Date:  2012-06-04       Impact factor: 6.085

Review 10.  The key role of sphingolipid metabolism in cancer: New therapeutic targets, diagnostic and prognostic values, and anti-tumor immunotherapy resistance.

Authors:  Run-Ze Li; Xuan-Run Wang; Jian Wang; Chun Xie; Xing-Xia Wang; Hu-Dan Pan; Wei-Yu Meng; Tu-Liang Liang; Jia-Xin Li; Pei-Yu Yan; Qi-Biao Wu; Liang Liu; Xiao-Jun Yao; Elaine Lai-Han Leung
Journal:  Front Oncol       Date:  2022-07-27       Impact factor: 5.738

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.